INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 21S · 3 late76 trades$25.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05CFCheng Chi Fung0B / 42S42 trades$15.33M
  6. 06RARothblatt Martine A0B / 33S33 trades$5.50M
  7. 07RJRubinstein Julie0B / 32S32 trades$5.55M
  8. 08LBLeach Bryan0B / 30S30 trades$7.97M
  9. 09AOAtay Oguzhan0B / 30S30 trades$7.55M
  10. 10JDJenkins William D Jr0B / 30S30 trades$13.38M

Form 4 transactions

18,937 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
TS
Thakar Sumedh SDirector, CEO & PRESIDENT
QLYSQUALYS, INC.
Open-market sale · 10b5-1 plan
SELL$76K
400 sh
Oct 14, 2026Oct 15, 2026
Page 66 of 474
← PrevNext →
traded Oct 14, 2026
+1d
SEC Form 4

Evidence

11
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$361K
463 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

11
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$296K
380 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

11
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$354K
454 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

11
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$292K
376 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

10
EW
Eddy Robert W.Director, President & CEO
BJBJ's Wholesale Club Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$1.81M
18.0K sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$522K
1,997 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$862K
3,283 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$404K
1,611 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$414K
1,644 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$258K
1,014 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$386K
1,544 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$394K
1,484 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$348K
1,320 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$426K
1,676 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$371K
1,468 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

8
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$51K
66 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

8
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$56K
74 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

8
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$167K
219 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

8
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$94K
121 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

8
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$163K
211 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

8
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$98K
127 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

8
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$207K
271 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

8
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$147K
192 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

8
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$81K
105 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

8
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$173K
224 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

8
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$214K
279 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

8
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$218K
283 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

7
EW
Eddy Robert W.Director, President & CEO
BJBJ's Wholesale Club Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$517K
5,000 sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC Form 4

Evidence

6
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$171K
640 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

6
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$220K
883 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

6
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$54K
200 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

6
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$126K
476 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

6
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$156K
600 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC Form 4

Evidence

5
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$4,523
6 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

5
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$21K
27 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

5
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$39K
50 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

5
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$18K
24 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

5
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$11K
14 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

5
MJ
Murphy Andrew JCo-Chief Scientific Officer
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$9,242
12 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC Form 4

Evidence

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K